Top In-Vitro Colorectal Cancer Screening Tests Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the In-Vitro Colorectal Cancer Screening Tests Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading In-Vitro Colorectal Cancer Screening Tests industry players.

In-Vitro Colorectal Cancer Screening Tests Market Competitive Landscape

The existence of several international players defines the global market. To increase their market share, businesses use a variety of techniques, including partnerships, agreements, regional growth, mergers, acquisitions, and new product creation. In our in-vitro colorectal cancer screening tests market reports, some of the leading quality in-vitro colorectal cancer screening tests manufacturers are as follows: Abbott (US), F. Hoffmann-La Roche AG (Switzerland), Quest Diagnostics (US), Sysmex Corporation (Japan), Siemens Healthcare (Germany), Alere Inc. (US), Eiken Chemical (Japan), Siemens AG (Germany), OncoCyte Corporation-Biotime (US), Merck KGaA (Germany).

Top Players in the Global In-Vitro Colorectal Cancer Screening Tests Market

  • Abbott Laboratories 
  • Beckman Coulter Inc 
  • Eiken Chemical Co., Ltd. 
  • Epigenomics 
  • Sysmex Corporation 
  • Siemens Healthcare GmbH 
  • Quest Diagnostics Incorporated 
  • OncoCyte Corporation 
  • Merck KGaA 
  • Immunostics Inc. 
  • Kyowa Kirin Co. Ltd. 
  • Randox Laboratories Ltd. 
  • R-Biopharm AG 
  • Bio-Rad Laboratories, Inc 
  • Exact Sciences Corporation 
  • F. Hoffmann-La Roche AG 
  • Genomic Health, Inc 
  • Hologic, Inc. 
  • Illumina, Inc. 
  • Invitae Corporation

In-Vitro Colorectal Cancer Screening Tests Market

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

In-Vitro Colorectal Cancer Screening Tests Market size was valued at USD 1.3 Billion in 2023 and is poised to grow from USD 1.4 Billion in 2024 to USD 2.3 Billion by 2032, growing at a CAGR of 6.5% during the forecast period (2025-2032).

The existence of several international players defines the global market. To increase their market share, businesses use a variety of techniques, including partnerships, agreements, regional growth, mergers, acquisitions, and new product creation. In our in-vitro colorectal cancer screening tests market reports, some of the leading quality in-vitro colorectal cancer screening tests manufacturers are as follows: Abbott (US), F. Hoffmann-La Roche AG (Switzerland), Quest Diagnostics (US), Sysmex Corporation (Japan), Siemens Healthcare (Germany), Alere Inc. (US), Eiken Chemical (Japan), Siemens AG (Germany), OncoCyte Corporation-Biotime (US), Merck KGaA (Germany). 'Abbott Laboratories ', 'Beckman Coulter Inc ', 'Eiken Chemical Co., Ltd. ', 'Epigenomics ', 'Sysmex Corporation ', 'Siemens Healthcare GmbH ', 'Quest Diagnostics Incorporated ', 'OncoCyte Corporation ', 'Merck KGaA ', 'Immunostics Inc. ', 'Kyowa Kirin Co. Ltd. ', 'Randox Laboratories Ltd. ', 'R-Biopharm AG ', 'Bio-Rad Laboratories, Inc ', 'Exact Sciences Corporation ', 'F. Hoffmann-La Roche AG ', 'Genomic Health, Inc ', 'Hologic, Inc. ', 'Illumina, Inc. ', 'Invitae Corporation'

The prevalence of colorectal cancer (CRC) is increasing as a result of numerous causes, including the ageing population, the adoption of an unhealthy lifestyle, and diabetes.

One of the main factors propelling the market's expansion is the rising frequency of colorectal cancer among the general population. Additionally, growing public awareness of the advantages of early cancer detection and prompt treatment is favourably affecting market expansion. The market is expanding as a result of numerous technological developments, such as the inclusion of genetic testing in cancer screening tests. These tests support early detection, the creation of treatment regimens, stopping the spread of cancerous cells, and lowering the dangers of afflicted conditions.

The North American, European, Asian-Pacific, Latin American, and Middle Eastern regions of the market for in-vitro colorectal cancer screening tests were used to split the market for regional analysis. In-vitro testing for colorectal cancer were the market leader in 2021 in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global In-Vitro Colorectal Cancer Screening Tests Market
In-Vitro Colorectal Cancer Screening Tests Market

Report ID: SQMIG35E2011

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE